Schwabe Taps Into Younger Audience With Braineffect Deal

By taking a majority stake in dynamic dietary supplements firm Braineffect, Germany's Schwabe can reach a new, younger target audience for its OTC herbal medicines.

(Shutterstock)

More from Deals

More from Strategy